SCHEMBL383466

SCHEMBL383466

CC(C)(C)OC(=O)NC1CCN(c2ccc(C(=O)NCCC(=O)ON(C(C)(C)C)S(=O)(=O)c3ccccc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.46
MAPK8 P45983 1/20 0.41
CKS1B P61024 1/20 0.41
SKP1 P63208 1/20 0.41
SKP2 Q13309 1/20 0.41
HPGDS O60760 1/20 0.41
NAMPT P43490 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KCNA3 P22001 1/20 0.39
ADRB3 P13945 1/20 0.39
DRD2 P14416 2/20 0.38
ITGB3 P05106 1/20 0.38
ITGAV P06756 1/20 0.38
ITGA2B P08514 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CASR P41180 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664584 0.85 CCR5 (0.42) CCR5MAPK8CKS1BSKP1SKP2
SCHEMBL383158 0.85 ITGB3 (0.44) HPGDSLMNASMN1; SMN2ALDH1A1ADRB3
SCHEMBL383350 0.82 CASR (0.42) HPGDSNAMPTALDH1A1ADRB3ITGB3
SCHEMBL383252 0.82 CASR (0.42) HPGDSNAMPTALDH1A1ADRB3ITGB3
SCHEMBL382570 0.81 SMN1; SMN2 (0.41) HPGDSSMN1; SMN2ALDH1A1ADRB3ITGB3
SCHEMBL383582 0.81 ITGB3 (0.59) HPGDSALDH1A1ADRB3ITGB3ITGAV
SCHEMBL460322 0.79 ITGB3 (0.40) HPGDSALDH1A1ADRB3ITGB3ITGAV
SCHEMBL6499244 0.78 CNR1 (0.38) ALDH1A1DRD2ITGB3ITGAVITGA2B
SCHEMBL382657 0.78 ALDH1A1 (0.42) LMNASMN1; SMN2ALDH1A1ITGB3ITGAV
SCHEMBL383095 0.77 ITGB3 (0.46) DRD2ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed